STOCKHOLDERS EQUITY (DEFICIT) (Details) - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Stockholders' Equity | ||
| Outstanding at beginning of the year | 4,100,000 | 2,000,000 |
| Granted during the year | 1,167,408 | 1,600,000 |
| Outstanding at end of the year | 5,267,408 | 3,600,000 |
| Stock warrants Exercisable at end of the year | 5,267,408 | 3,600,000 |
| Weighted average remaining life | 1 year 3 months 18 days | |
| Weighted Average Exercise price outstanding beginning of the year | $ 0.68 | $ 0.10 |
| Weighted Average Exercise price Granted during the year | 0.44 | 1.15 |
| Weighted Average Exercise price exercised during the year | 0.00 | 0 |
| Weighted Average Exercise price expired during the year | 0.00 | 0 |
| Weighted Average Exercise price outstanding ending of the year | 0.63 | 0.57 |
| Weighted Average Exercise price exercisable end of the year | $ 0.63 | $ 0.57 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares of other common stock instruments held by shareholder, including, but not limited to, exchangeable shares. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|